This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Deficient DNA Mismatch Repair

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Deficient DNA Mismatch Repair Means

Deficient DNA Mismatch Repair (dMMR) refers to cells that have lost the ability to fix mistakes made when DNA is copied during cell division. Normally, a group of genes called mismatch repair genes work to correct these errors to keep DNA stable. When these genes don’t work properly, errors build up, causing many mutations in the DNA. This can increase the chance that cells become cancerous.

Why It Matters in Cancer Care

Knowing whether a tumor has deficient mismatch repair is important because it can affect how the cancer behaves and responds to treatment. Tumors with dMMR often have many mutations, which may make them more visible to the immune system or more sensitive to certain drugs. Testing for dMMR is especially common in colorectal, gastrointestinal, and endometrial cancers, but it can also be relevant in other cancers and inherited conditions like Lynch syndrome.

Where You Might See This Term

You may encounter the term dMMR or mismatch repair deficiency in your medical reports, pathology results, treatment plans, or discussions about clinical trials and drug options. It may appear under several names, including deficient mismatch repair, MMR deficiency, or mismatch repair deficiency. Because of this variety, it’s helpful to compare the wording and ask your care team to explain what it means for your specific case.

What It Does Not Automatically Mean

Finding dMMR in a tumor is not a diagnosis by itself, nor does it directly tell you what treatment you will receive. It is one piece of information that doctors use alongside other tests and clinical details. It does not mean the cancer is more or less serious on its own, and it does not guarantee a particular outcome. Each person’s situation is unique.

How Doctors Use This Information

Doctors may test for dMMR to help guide treatment decisions, such as whether certain immunotherapy drugs might be effective. It can also help identify inherited conditions like Lynch syndrome, which may affect cancer risk for family members. This information can be part of diagnosis, staging, treatment planning, and follow-up care.

Common Confusions and Questions to Ask

Because dMMR has several names and appears in different contexts, it can be confusing. Patients often wonder what it means for their cancer type, treatment options, and prognosis. Good questions to ask your care team include: What does dMMR mean for my cancer? How does it affect my treatment choices? Is this related to inherited cancer risk? What tests were done to find this? Understanding the context helps avoid misunderstandings.

Reading the Term in Context

Always consider dMMR as part of a larger medical picture. It is not a standalone diagnosis or treatment plan. If you see it in a report or discussion, ask how it fits with other findings and what it means for your care. Your healthcare team can explain how this information is used to personalize your treatment.

Safety and Next Steps

This explanation is for education only and does not replace medical advice. If you see the term deficient DNA mismatch repair in your records or hear it from your care team, the best next step is to ask them directly what it means for you. They can provide information tailored to your diagnosis, treatment options, and personal health situation.

Sources

Public source information used for this glossary entry includes: